Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Magadanenergo reported for 2023 by IFRS

4/8/24 MAGE

Mosgorlombard reported for 2023 by IFRS

4/8/24 MGKL

INARCTICA reported for 2023 by RAS

4/8/24 AQUA

Globaltrans reports for 2023 by IFRS

4/8/24 GLTR

Lukoil entered a projects on Caspian Sea shelf

4/8/24 LKOH

RESK reported for 2023 by IFRS

4/5/24 RZSB

Kamchatskenergo reported for 2023 by IFRS

4/5/24 KCHE

DEC reported for 2023 by IFRS

4/5/24 DVEC

YTEK reported for 2023 by RAS

4/5/24 YAKG

ITC reported for 2023 by IFRS

4/5/24 WTCM